These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23357129)

  • 21. Philosophy of antiarrhythmic approaches to ventricular tachyarrhythmias close to the 21st century.
    Breithardt G; Haverkamp W; Böcker D; Borggrefe M
    Rev Port Cardiol; 1998 Dec; 17(12):981-91. PubMed ID: 9973859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of ventricular tachycardia with ablation therapy in a patient with a previously implanted cardioverter defibrillator.
    Porterfield JG; Porterfield LM; Fiallo LA
    J Invasive Cardiol; 1995 Mar; 7(2):53-6. PubMed ID: 10155714
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms, prediction and treatment of ventricular tachyarrhythmias occurring late after myocardial infarction.
    Denniss AR; Richards DA
    Heart Lung Circ; 2007 Jun; 16(3):156-61. PubMed ID: 17448725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is programmed ventricular stimulation still up to date in the medicinal evaluation of ventricular tachycardia?].
    Kouakam C; Guédon-Moreau L; Kacet S
    Therapie; 1998; 53(6):533-41. PubMed ID: 10070230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction.
    Kato M; Dote K; Sasaki S; Takemoto H; Habara S; Hasegawa D
    Chest; 2004 Sep; 126(3):702-8. PubMed ID: 15364745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.
    Almendral J; Josephson ME
    Circulation; 2007 Sep; 116(10):1204-12. PubMed ID: 17768304
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
    Moss AJ; Hall WJ; Cannom DS; Daubert JP; Higgins SL; Klein H; Levine JH; Saksena S; Waldo AL; Wilber D; Brown MW; Heo M
    N Engl J Med; 1996 Dec; 335(26):1933-40. PubMed ID: 8960472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-infarction sustained ventricular tachycardias. The role of drugs and methods for assessing antiarrhythmic efficacy.
    Campbell RW
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():33-6. PubMed ID: 8734162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ventricular tachycardia and ventricular fibrillation. Diagnostic procedure for selection of patients for non-medicamentous therapeutic procedures].
    Schmidinger H
    Wien Med Wochenschr; 1992; 142(15-16):341-6. PubMed ID: 1481538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology and management of sustained ventricular tachycardia.
    Talwar KK; Naik N
    Am J Cardiovasc Drugs; 2001; 1(3):179-92. PubMed ID: 14728033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ventricular tachyarrhythmia in acute and chronic myocardial ischemia: value of diagnostic procedures].
    Steinbeck G
    Z Kardiol; 1993; 82 Suppl 5():149-54. PubMed ID: 8154156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current treatment of ventricular arrhythmias: state of the art.
    Stevenson WG
    Heart Rhythm; 2013 Dec; 10(12):1919-26. PubMed ID: 24120875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unsustained ventricular tachycardia--to treat or not to treat.
    Friedman PL; Stevenson WG
    N Engl J Med; 1996 Dec; 335(26):1984-5. PubMed ID: 8960480
    [No Abstract]   [Full Text] [Related]  

  • 38. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
    Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator.
    Elgarhi N; Kreuz J; Balta O; Nickenig G; Hoium H; Lewalter T; Schwab JO
    Heart; 2008 Apr; 94(4):e16. PubMed ID: 17639096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.